CLASS II Device recall · Reported 25 Apr 2018 · FDA Enforcement Report

Jamshidi (TJ) Needle Bone Marrow [a.), b.), c.), d.), e.)]; Sterile recalled

Carefusion 2200 is recalling Jamshidi (TJ) Needle Bone Marrow [a.), b.), c.), d.), e.)]; Sterile, distributed nationwide in the US. The recall was initiated on 23 Feb 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesProduct Code: a.) TJC3513 / LOT 0000848831, 0000851431, 0000854856; Product Code: b.) TJC4008 / LOT 0000841227, 0000846706, 0000848560, 0000849684, 0000853455; c.) TJC4011 / LOT 0000840667, 0000841228, 0000845874, 0000849717, 0000850937, 0000852121; d.) TJC6008 / LOT 0000841216, 0000848569, 0000851432, 0000852122, 0000853458; e.) TJC6011 / LOT 0000841124, 0000848571, 0000853975

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1424-2018
FDA event ID
76620
Recalling firm
Carefusion 2200, Vernon Hills, IL
Classification
Class II
Status
Terminated
Recall initiated
23 Feb 2017
FDA classified
18 Apr 2018
Reported
25 Apr 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

23 Feb 2017Recall initiated by company
18 Apr 2018Classified by FDA+419 days
25 Apr 2018Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The integrity of the sterile packaging is potentially compromised.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

JAMSHIDI (TJ) NEEDLE BONE MARROW [a.) 13G x 3.5, b.) 8G x 4, c.) 11G x 4, d.) 8G x 6, e.) 11G x 6]; STERILE;

Where it was distributed

Nationwide, Australia, Brazil, Canada, China, Japan, Kuwait, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Singapore, South Africa, Taiwan, Thailand, United Arab Emirates, Vietnam

Nationwide

Questions about this recall

Is Jamshidi (TJ) Needle Bone Marrow [a.), b.), c.), d.), e.)]; Sterile recalled?

Yes. Carefusion 2200 recalled Jamshidi (TJ) Needle Bone Marrow [a.), b.), c.), d.), e.)]; Sterile on 23 Feb 2017. The recall is Class II and its status is Terminated. Recall number Z-1424-2018.

Why was it recalled?

The integrity of the sterile packaging is potentially compromised.

Which lots are affected?

Product Code: a.) TJC3513 / LOT 0000848831, 0000851431, 0000854856; Product Code: b.) TJC4008 / LOT 0000841227, 0000846706, 0000848560, 0000849684, 0000853455; c.) TJC4011 / LOT 0000840667, 0000841228, 0000845874, 0000849717, 0000850937, 0000852121; d.) TJC6008 / LOT 0000841216, 0000848569, 0000851432, 0000852122, 0000853458; e.) TJC6011 / LOT 0000841124, 0000848571, 0000853975

Where was it sold?

Nationwide, Australia, Brazil, Canada, China, Japan, Kuwait, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Singapore, South Africa, Taiwan, Thailand, United Arab Emirates, Vietnam

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Carefusion 2200

All 112

Other Syringes & Needles recalls

All 1,060